Paper Details

  1. Home
  2. Paper Details

A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder.

Author: BrakouliasVlasios, StockingsEmily

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Risperidone, paliperidone and aripiprazole are supported by evidence as augmentation agents for OCD in adults. More studies are needed to assess predictors of response and detect any differential effects between the three agents.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: Obsessive-compulsive disorder (OCD) is often viewed as a difficult to treat disorder. In some patients, antipsychotics are used to augment the action of serotonin reuptake inhibitors (SRIs), particularly when there is only a partial response to treatment. AREAS COVERED: This comprehen...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14656566.2018.1540590

データ提供：米国国立医学図書館（NLM）

Navigating the Sands of Obsessive-Compulsive Disorder: A Camel's Perspective

Obsessive-compulsive disorder (OCD) is a mental health condition that can feel like a never-ending desert of repetitive thoughts and behaviors. This systematic review explores the effectiveness of atypical antipsychotics, such as risperidone, paliperidone, and aripiprazole, as augmenting agents for OCD treatment. The authors reviewed the available research on these medications, considering their effectiveness and tolerability in combination with serotonin reuptake inhibitors (SRIs).

Finding a Path to Relief from OCD

The review suggests that antipsychotic augmentation may be a viable option for patients who experience only partial relief from SRIs and exposure and response prevention therapy. While evidence supports the use of risperidone, paliperidone, and aripiprazole as augmenting agents, the authors call for further research with larger sample sizes to better understand the predictors of response and potential differences between these medications.

A Camel's Reminder: Seeking Expert Guidance

The desert of OCD can be challenging, and it's essential to work with a healthcare professional to find the best treatment path. They can help determine if antipsychotic augmentation is appropriate and guide you through the complexities of medication choices. Remember, there are many paths to relief, and finding the right one for your unique journey is crucial.

Dr. Camel's Conclusion

This systematic review offers valuable insights into the potential of atypical antipsychotics as augmenting agents for OCD. While more research is needed, these medications may provide a valuable tool for those seeking relief from the challenging desert of OCD. Remember, seeking expert guidance and collaborating with your healthcare provider is essential in navigating the complexities of mental health conditions and finding the most effective treatment path for you.

Date :
  1. Date Completed 2019-04-03
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

30360669

DOI: Digital Object Identifier

10.1080/14656566.2018.1540590

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.